Related Experiment Video
Updated: May 14, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
Acute anterior uveitis following intravitreal injection of bevacizumab
1Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York 10461, USA. ophthoman@ymail.com
Background And Objective:
To report five cases of iritis after intravitreal injection of bevacizumab.
Patients And Methods:
The clinical charts of patients who received intravitreal injections of bevacizumab or ranibizumab from January 2009 to September 2011 by one physician were retrospectively reviewed.
Results:
A total of 1,097 injections of bevacizumab and 571 of ranibizumab were administered. Five patients developed acute anterior uveitis and presented with severe pain, photophobia, conjunctival injection, and anterior chamber reaction 2 to 24 hours after intravitreal injection of bevacizumab. All five patients were treated with topical corticosteroids with rapid resolution of the inflammation.
Conclusion:
Although uncommon, acute iritis is a complication of intravitreal injection of bevacizumab.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
